Doxorubicin‐induced heart failure in cancer patients: A cohort study based on the Korean National Health Insurance Database

BACKGROUND: Doxorubicin is a typical anticancer drug that causes cardiomyopathy and heart failure (HF). The aim of our study was to investigate incidence, risk factors for doxorubicin‐induced HF in Korean cancer patients and their survival rate, utilizing a nationwide population‐based cohort. METHOD...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Young Ae, Cho, Hyunsoon, Lee, Nayoung, Jung, So‐Youn, Sim, Sung Hoon, Park, In Hae, Lee, Sunmi, Lee, Eun Sook, Kim, Hak Jin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Clinical Cancer Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6308087/
https://www.ncbi.nlm.nih.gov/pubmed/30453386
http://dx.doi.org/10.1002/cam4.1886

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6308087/
https://www.ncbi.nlm.nih.gov/pubmed/30453386
http://dx.doi.org/10.1002/cam4.1886

Ejemplares similares